The effect of dexmedetomidine on renal function in patients undergoing cardiac valve replacement under cardiopulmonary bypass: A double-blind randomized controlled trial

Journal of Clinical Anesthesia

Volumn 40, Issue , 2017, Pages 33-38

  Zhai, Mingyu ^a,b   Kang, Fang ^b   Han, Mingming ^b   Huang, Xiang ^b   Li, Juan ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Acute kidney injury; Cardiac valve replacement; Cardiopulmonary bypass; Dexmedetomidine

Indexed keywords

CREATININE; DEXMEDETOMIDINE; INTERLEUKIN 8; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PLACEBO; SUPEROXIDE DISMUTASE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HEART VALVE REPLACEMENT; HUMAN; INCIDENCE; INTRAOPERATIVE PERIOD; KIDNEY FUNCTION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; BLOOD; DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; MICTURITION; MIDDLE AGED; PERIOPERATIVE PERIOD; PROCEDURES; URINE; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ADULT; AGED; BIOMARKERS; BLOOD UREA NITROGEN; CARDIOPULMONARY BYPASS; CREATININE; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTERLEUKIN-8; LIPOCALIN-2; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; URINATION; YOUNG ADULT;

EID: 85017522142     PISSN: 09528180     EISSN: 18734529     Source Type: Journal    
DOI: 10.1016/j.jclinane.2017.03.053     Document Type: Article

References (30)

1. [1] Paparella, D., Yau, T.M., Young, E., Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21 (2002), 232–244.
2. [2] Schilling, K.M., Moussavian, R.M., Slotta, E.J., et al. Hemoglobin induces cytotoxic damage of glycine-preserved renal tubules: 1148. Transplantation, 86, 2008.
3. [3] Staffordsmith, M., Shaw, A., Swaminathan, M., Cardiac surgery and acute kidney injury: emerging concepts. Curr Opin Crit Care 15 (2009), 498–502.
4. [4] Bihorac, A., Yavas, S., Subbiah, S., Hobson, C., Schold, J., Gabrielli, A., et al. Long-term risk of mortality and acute kidney injury during hospitalization after major surgery. Ann Surg 249 (2009), 851–858.
5. [5] Cheung, C.W., Qiu, Q., Liu, J., Chu, K.M., Irwin, M.G., Intranasal dexmedetomidine in combination with patient-controlled sedation during upper gastrointestinal endoscopy: a randomised trial. Acta Anaesthesiol Scand 59 (2015), 215–223.
6. [6] Cheung, C.W., Ng, K.F.J., Liu, J., Yuen, M.Y.V., Ho, M.H.A., Irwin, M.G., Analgesic and sedative effects of intranasal dexmedetomidine in third molar surgery under local anaesthesia. BJA British Journal of Anaesthesia 107 (2011), 430–437.
7. [7] Huang, J., Dinh, M., Kuchle, N., Zhou, J., Anesthetic management for combined mitral valve replacement and aortic valve repair in a patient with osteogenesis imperfecta. Ann Card Anaesth 14 (2011), 115–118.
8. [8] Torbic, H., Papadopoulos, S., Manjourides, J., Devlin, J.W., Impact of a protocol advocating dexmedetomidine over propofol sedation after robotic-assisted direct coronary artery bypass surgery on duration of mechanical ventilation and patient safety. Ann Pharmacother 47 (2013), p1021–p1029.
9. [9] Sugita, S., Okabe, T., Sakamoto, A., Continuous infusion of dexmedetomidine improves renal ischemia-reperfusion injury in rat kidney. J Nippon Med Sch Nippon Ika Daigaku Zasshi 80 (2013), 131–139.
10. [10] Bellomo, R., Ronco, C., Kellum, J., Mehta, R., Palevsky, P., Workgroup ADQI, Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 8 (2004), R204–R212.
11. [11] Bellomo, R., Kellum, J.A., Ronco, C., Acute kidney injury. Lancet 380 (2012), 756–766.
12. [12] Borthwick, E., Ferguson, A., Perioperative acute kidney injury: risk factors, recognition, management, and outcomes. BMJ, 341, 2010, 67.
13. [13] Englberger, L., Suri, R.M., Greason, K.L., Burkhart, H.M., Sundt, T.M. III, et al. Deep hypothermic circulatory arrest is not a risk factor for acute kidney injury in thoracic aortic surgery. J Thorac Cardiovasc Surg 141 (2011), 552–558.
14. [14] Grayson, A.D., Khater, M.M., Fox, M.A., Valvular heart operation is an independent risk factor for acute renal failure. Ann Thorac Surg 75 (2003), 1829–1835.
15. [15] Jalonen, J., Hynynen, M., Kuitunen, A., Heikkilä, H., Perttilä, J., Salmenperä, M., et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 86 (1997), 331–345.
16. [16] Khan, Z.P., Ferguson, C.N., Jones, R.M., Alpha-2 and imidazoline receptor agonistsTheir pharmacology and therapeutic role. Anaesthesia 54 (1999), 146–165.
17. [17] Leino, K., Hynynen, M., Jalonen, J., Salmenperä, M., Scheinin, H., Aantaa, R., Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol 11 (2011), 1–10.
18. [18] Yang, C.L., Chen, C.H., Tsai, P.S., Wang, T.Y., Huang, C.J., Protective effects of dexmedetomidine-ketamine combination against ventilator-induced lung injury in endotoxemia rats. J Surg Res 167 (2011), 273–281.
19. [19] Sanders, R.D., Xu, J., Shu, Y., Januszewski, A., Halder, S., Fidalgo, A., et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Journal of the American Society of Anesthesiologists 110 (2009), 1077–1085.
20. [20] Okada, H., Kurita, T., Mochizuki, T., Morita, K., Sato, S., The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearts. Resuscitation 74 (2007), 538–545.
21. [21] Harada, T., Constantinou, C.E., The effect of alpha 2 agonists and antagonists on the lower urinary tract of the rat. J Urol 149 (1993), 159–164.
22. [22] Frumento, R.J., Logginidou, H.G., Wahlander, S., Wagener, G., Playford, H.R., Sladen RN dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. J Clin Anesth 18 (2006), 422–426.
23. [23] Ji, F., Li, Z., Young, J.N., Yeranossian, A., Liu, H., Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One 8 (2013), 1002–1004.
24. [24] Shirasaka, T., Kannan, H., Takasaki, M., Activation of a G protein-coupled inwardly rectifying K + current and suppression of Ih contribute to dexmedetomidine-induced inhibition of rat hypothalamic paraventricular nucleus neurons. Anesthesiology 107 (2007), 605–615.
25. [25] Escobales, N., Crespo, M.J., Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol 3 (2005), 231–246.
26. [26] Cruz, D.N., Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 36 (2009), 444–451.
27. [27] Parikh, C.R., Mishra, J., Thiessen-Philbrook, H., Dursun, B., Ma, Q., Kelly, C., et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 70 (2006), 199–203.
28. [28] Haasefielitz, A., Bellomo, R., Devarajan, P., Story, D., Matalanis, G., Dragun, D., et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery–a prospective cohort study. Crit Care Med 37 (2009), 553–560.
29. [29] Bahar, I., Akgul, A., Ozatik, M.A., Vural, K.M., Demirbag, A.E., Boran, M., et al. Acute renal failure following open heart surgery: risk factors and prognosis. Perfusion 20 (2005), 317–322.
30. [30] Kistvan, J.E., Goedvolk, C.A., Doornaar, M.B., Vorst, M.M., Bosman-Vermeeren, J.M., Brand, R., et al. Acute renal insufficiency and renal replacement therapy after pediatric cardiopulmonary bypass surgery. Pediatr Cardiol 22 (2001), 321–326.